Literature DB >> 9284812

Osteonectin (SPARC) expression in human liver and in cultured human liver myofibroblasts.

S Blazejewski1, B Le Bail, L Boussarie, J F Blanc, L Malaval, K Okubo, J Saric, P Bioulac-Sage, J Rosenbaum.   

Abstract

Osteonectin/SPARC is a glycoprotein involved in the regulation of cell shape, adhesion, migration, and proliferation. It also has complex effects on extracellular matrix synthesis and turnover. We found that osteonectin mRNA was very abundant in a human liver myofibroblast library. Using Northern and Western blot, immunoprecipitation, and radioimmunoassay, we found that cultured liver myofibroblasts actively secreted osteonectin. Myofibroblasts are very rare in normal liver but proliferate during liver fibrosis where they synthesize extracellular matrix components. Thus, we studied the distribution of osteonectin in normal and fibrotic human liver using in situ hybridization. Osteonectin mRNA expression was weak in normal liver but very high in fibrotic liver within fibrous septae and scattered sinusoidal cells. Serial sectioning and double staining experiments with an antibody to smooth muscle alpha-actin showed that osteonectin transcripts were mostly co-localized with myofibroblasts. In conclusion, osteonectin is highly expressed in human liver myofibroblasts in culture as well as in human liver fibrosis in vivo. The many biological properties of osteonectin make it a candidate effector of human liver fibrogenesis.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9284812      PMCID: PMC1857832     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  30 in total

1.  Large scale cDNA sequencing for analysis of quantitative and qualitative aspects of gene expression.

Authors:  K Okubo; N Hori; R Matoba; T Niiyama; A Fukushima; Y Kojima; K Matsubara
Journal:  Nat Genet       Date:  1992-11       Impact factor: 38.330

2.  Expression of platelet-derived growth factor and its receptors in normal human liver and during active hepatic fibrogenesis.

Authors:  M Pinzani; S Milani; H Herbst; R DeFranco; C Grappone; A Gentilini; A Caligiuri; G Pellegrini; D V Ngo; R G Romanelli; P Gentilini
Journal:  Am J Pathol       Date:  1996-03       Impact factor: 4.307

3.  Immunolocalization of SPARC, tenascin, and thrombospondin in pulmonary fibrosis.

Authors:  C Kuhn; R J Mason
Journal:  Am J Pathol       Date:  1995-12       Impact factor: 4.307

4.  Monitoring cell physiology by expression profiles and discovering cell type-specific genes by compiled expression profiles.

Authors:  K Okubo; K Itoh; A Fukushima; J Yoshii; K Matsubara
Journal:  Genomics       Date:  1995-11-20       Impact factor: 5.736

5.  Osteonectin, a bone-specific protein linking mineral to collagen.

Authors:  J D Termine; H K Kleinman; S W Whitson; K M Conn; M L McGarvey; G R Martin
Journal:  Cell       Date:  1981-10       Impact factor: 41.582

6.  Expression of SPARC in normal and fibrotic livers.

Authors:  E Frizell; S L Liu; A Abraham; I Ozaki; M Eghbali; E H Sage; M A Zern
Journal:  Hepatology       Date:  1995-03       Impact factor: 17.425

7.  Human myofibroblastlike cells obtained by outgrowth are representative of the fibrogenic cells in the liver.

Authors:  S Blazejewski; A M Preaux; A Mallat; I Brocheriou; P Mavier; D Dhumeaux; D Hartmann; D Schuppan; J Rosenbaum
Journal:  Hepatology       Date:  1995-09       Impact factor: 17.425

8.  SPARC is a source of copper-binding peptides that stimulate angiogenesis.

Authors:  T F Lane; M L Iruela-Arispe; R S Johnson; E H Sage
Journal:  J Cell Biol       Date:  1994-05       Impact factor: 10.539

9.  Distribution of SPARC in normal and neoplastic human tissue.

Authors:  P L Porter; E H Sage; T F Lane; S E Funk; A M Gown
Journal:  J Histochem Cytochem       Date:  1995-08       Impact factor: 2.479

10.  Fibroblast growth factor 2 and transforming growth factor beta 1 interactions in human liver myofibroblasts.

Authors:  J Rosenbaum; S Blazejewski; A M Préaux; A Mallat; D Dhumeaux; P Mavier
Journal:  Gastroenterology       Date:  1995-12       Impact factor: 22.682

View more
  13 in total

1.  EPA and DHA elicit distinct transcriptional responses to high-fat feeding in skeletal muscle and liver.

Authors:  Hawley E Kunz; Surendra Dasari; Ian R Lanza
Journal:  Am J Physiol Endocrinol Metab       Date:  2019-07-02       Impact factor: 4.310

Review 2.  Matricellular proteins in the trabecular meshwork: review and update.

Authors:  Ayan Chatterjee; Guadalupe Villarreal; Douglas J Rhee
Journal:  J Ocul Pharmacol Ther       Date:  2014-06-05       Impact factor: 2.671

3.  SPARC downregulation attenuates the profibrogenic response of hepatic stellate cells induced by TGF-β1 and PDGF.

Authors:  Catalina Atorrasagasti; Jorge B Aquino; Leonardo Hofman; Laura Alaniz; Mariana Malvicini; Mariana Garcia; Lorena Benedetti; Scott L Friedman; Osvaldo Podhajcer; Guillermo Mazzolini
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2011-02-10       Impact factor: 4.052

Review 4.  Secreted Protein Acidic and Rich in Cysteine in Ocular Tissue.

Authors:  Kurt Scavelli; Ayan Chatterjee; Douglas J Rhee
Journal:  J Ocul Pharmacol Ther       Date:  2015-07-13       Impact factor: 2.671

5.  SPARC (secreted protein acidic and rich in cysteine) knockdown protects mice from acute liver injury by reducing vascular endothelial cell damage.

Authors:  E Peixoto; C Atorrasagasti; J B Aquino; R Militello; J Bayo; E Fiore; F Piccioni; E Salvatierra; L Alaniz; M G García; R Bataller; F Corrales; M Gidekel; O Podhajcer; M I Colombo; G Mazzolini
Journal:  Gene Ther       Date:  2014-11-20       Impact factor: 5.250

Review 6.  The role of SPARC (secreted protein acidic and rich in cysteine) in the pathogenesis of obesity, type 2 diabetes, and non-alcoholic fatty liver disease.

Authors:  Catalina Atorrasagasti; Agostina M Onorato; Guillermo Mazzolini
Journal:  J Physiol Biochem       Date:  2022-08-26       Impact factor: 5.080

7.  Secreted protein acidic and rich in cysteine (SPARC) in human skeletal muscle.

Authors:  Louise H Jørgensen; Stine J Petersson; Jeeva Sellathurai; Ditte C Andersen; Susanne Thayssen; Dorte J Sant; Charlotte H Jensen; Henrik D Schrøder
Journal:  J Histochem Cytochem       Date:  2008-09-15       Impact factor: 2.479

8.  The Function of SPARC as a Mediator of Fibrosis.

Authors:  Jessica Trombetta-Esilva; Amy D Bradshaw
Journal:  Open Rheumatol J       Date:  2012-06-15

9.  Molecular characterisation of transport mechanisms at the developing mouse blood-CSF interface: a transcriptome approach.

Authors:  Shane A Liddelow; Sally Temple; Kjeld Møllgård; Renate Gehwolf; Andrea Wagner; Hannelore Bauer; Hans-Christian Bauer; Timothy N Phoenix; Katarzyna M Dziegielewska; Norman R Saunders
Journal:  PLoS One       Date:  2012-03-21       Impact factor: 3.240

10.  Lack of the matricellular protein SPARC (secreted protein, acidic and rich in cysteine) attenuates liver fibrogenesis in mice.

Authors:  Catalina Atorrasagasti; Estanislao Peixoto; Jorge B Aquino; Néstor Kippes; Mariana Malvicini; Laura Alaniz; Mariana Garcia; Flavia Piccioni; Esteban J Fiore; Juan Bayo; Ramón Bataller; Elizabeth Guruceaga; Fernando Corrales; Osvaldo Podhajcer; Guillermo Mazzolini
Journal:  PLoS One       Date:  2013-02-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.